{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:51:35Z","timestamp":1792097495891,"version":"4.4.0"},"reference-count":40,"publisher":"Japan Atherosclerosis Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2023,3,1]]},"DOI":"10.5551\/jat.63593","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T22:11:37Z","timestamp":1654121497000},"page":"287-298","source":"Crossref","is-referenced-by-count":6,"title":["Injury Precipitating Tissue Loss and Time to Referral to a Vascular Center in Patients with Chronic Limb-Threatening Ischemia"],"prefix":"10.5551","volume":"30","author":[{"given":"Mitsuyoshi","family":"Takahara","sequence":"first","affiliation":[{"name":"Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Iida","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Kansai Rosai Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Ohura","sequence":"additional","affiliation":[{"name":"Department of Plastic, Reconstructive Surgery, Kyorin University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimitsu","family":"Soga","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terutoshi","family":"Yamaoka","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Matsuyama Red Cross Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyoshi","family":"Azuma","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Asahikawa Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","unstructured":"1) Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Rother J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C and Desormais I: 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J, 2018; 39: 763-816"},{"key":"2","unstructured":"2) Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR and Murad MH: Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg, 2019; 69: 3S-125S e140"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RA, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D and Walsh ME: 2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 2017; 135: e726-e779","DOI":"10.1161\/CIR.0000000000000471"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ and Lipsky BA: Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev, 2020; 36 Suppl 1: e3266","DOI":"10.1002\/dmrr.3266"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Takahara M, Iida O, Soga Y, Kodama A, Terashi H, Utsunomiya M, Okazaki J and Azuma N: Duration from Wound Occurrence to Referral to a Vascular Center in Japanese Patients with Critical Limb Ischemia. Ann Vasc Dis, 2020; 13: 56-62","DOI":"10.3400\/avd.oa.19-00102"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Machan LS, Snyder SA, O\u2019Leary EE, Ragheb AO and Zeller T: Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial. Circulation, 2016; 133: 1472-1483; discussion 1483","DOI":"10.1161\/CIRCULATIONAHA.115.016900"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Muller-Hulsbeck S, Keirse K, Zeller T, Schroe H and Diaz-Cartelle J: Long-Term Results from the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Femoropopliteal Treatment: 3-Year Follow-up. Cardiovasc Intervent Radiol, 2017; 40: 1832-1838","DOI":"10.1007\/s00270-017-1771-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Laird JR, Schneider PA, Tepe G, Brodmann M, Zeller T, Metzger C, Krishnan P, Scheinert D, Micari A, Cohen DJ, Wang H, Hasenbank MS and Jaff MR: Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA. J Am Coll Cardiol, 2015; 66: 2329-2338","DOI":"10.1016\/j.jacc.2015.09.063"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, Brodmann M, Pilger E, Zeller T, Krishnan P, Gammon R, Muller-Hulsbeck S, Nehler MR, Benenati JF and Scheinert D: Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. N Engl J Med, 2015; 373: 145-153","DOI":"10.1056\/NEJMoa1406235"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Lammer J, Zeller T, Hausegger KA, Schaefer PJ, Gschwendtner M, Mueller-Huelsbeck S, Rand T, Funovics M, Wolf F, Rastan A, Gschwandtner M, Puchner S, Ristl R and Schoder M: Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). J Am Coll Cardiol, 2013; 62: 1320-1327","DOI":"10.1016\/j.jacc.2013.05.079"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Garcia LA, Rosenfield KR, Metzger CD, Zidar F, Pershad A, Popma JJ, Zaugg M and Jaff MR: SUPERB final 3-year outcomes using interwoven nitinol biomimetic supera stent. Catheter Cardiovasc Interv, 2017; 89: 1259-1267","DOI":"10.1002\/ccd.27058"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Iida O, Takahara M and Mano T: Evidence-Experience Gap and Future Perspective on the Treatment of Peripheral Artery Disease. J Atheroscler Thromb, 2021; 28: 1251-1259","DOI":"10.5551\/jat.RV17058"},{"key":"13","unstructured":"13) The Japanese Circulation Society.: Guidelines for the management of peripheral arterial occlusive diseases (JCS 2015). https:\/\/plaza.umin.ac.jp\/~jscvs\/wordpress\/wp-content\/uploads\/2020\/06\/JCS2015_miyata_h.pdf (in Japanese) (Accessed Apr 16, 2022),"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Mills JL, Sr., Conte MS, Armstrong DG, Pomposelli FB, Schanzer A, Sidawy AN and Andros G: The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg, 2014; 59: 220-234 e221-222","DOI":"10.1016\/j.jvs.2013.08.003"},{"key":"15","unstructured":"15) Ohura N, Sakisaka M, Sekiyama T, Matsunaga H, Terabe Y, Mirishige Y, Kinoshita M and Takushima A: A Podiatric Healthcare System for Hemodialysis Patients. Japanese Journal of Foot Care, 2017; 15: 155-159 (in Japanese)"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Takahara M, Iida O, Kohsaka S, Soga Y, Fujihara M, Shinke T, Amano T and Ikari Y: Presentation Pattern of Lower Extremity Endovascular Intervention versus Percutaneous Coronary Intervention. J Atheroscler Thromb, 2020; 27: 761-768","DOI":"10.5551\/jat.53330"},{"key":"17","unstructured":"17) The Japanese Circulation Society. and The Japanese Society for Vascular Surgery.: JCS\/JSVS 2022 Guideline on the Management of Peripheral Arterial Disease. https:\/\/www.j-circ.or.jp\/cms\/wp-content\/uploads\/2022\/03\/JCS2022_Azuma.pdf (in Japanese) (Accessed Apr 16, 2022),"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, Lavery LA, Lemaster JW, Mills JL, Sr., Mueller MJ, Sheehan P and Wukich DK: Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care, 2008; 31: 1679-1685","DOI":"10.1093\/ptj\/88.11.1436"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Takahara M, Okuno S, Nakamura I, Iida O, Tsujimura T, Hata Y, Fujita Y and Haneda M: Prospective study on clinical characteristics of Japanese diabetic patients with chronic limb-threatening ischemia presenting Fontaine stage IV. Diabetol Int, 2020; 11: 33-40","DOI":"10.1007\/s13340-019-00399-5"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Kimura T, Watanabe Y, Tokuoka S, Nagashima F, Ebisudani S and Inagawa K: Utility of skin perfusion pressure values with the Society for Vascular Surgery Wound, Ischemia, and foot Infection classification system. J Vasc Surg, 2019; 70: 1308-1317","DOI":"10.1016\/j.jvs.2019.01.045"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Farber A: Chronic Limb-Threatening Ischemia. N Engl J Med, 2018; 379: 171-180","DOI":"10.1056\/NEJMcp1709326"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Azuma N, Takahara M, Kodama A, Soga Y, Terashi H, Tazaki J, Yamaoka T, Koya A and Iida O: Predictive Model for Mortality Risk Including the Wound, Ischemia, Foot Infection Classification in Patients Undergoing Revascularization for Critical Limb Ischemia. Circ Cardiovasc Interv, 2019; 12: e008015","DOI":"10.1161\/CIRCINTERVENTIONS.119.008015"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Shiraki T, Iida O, Takahara M, Soga Y, Yamauchi Y, Hirano K, Kawasaki D, Fujihara M, Utsunomiya M, Tazaki J, Yamaoka T, Shintani Y, Suematsu N, Suzuki K, Miyashita Y, Tsuchiya T and Uematsu M: Predictors of delayed wound healing after endovascular therapy of isolated infrapopliteal lesions underlying critical limb ischemia in patients with high prevalence of diabetes mellitus and hemodialysis. Eur J Vasc Endovasc Surg, 2015; 49: 565-573","DOI":"10.1016\/j.ejvs.2015.01.017"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Azuma N, Uchida H, Kokubo T, Koya A, Akasaka N and Sasajima T: Factors influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery? Eur J Vasc Endovasc Surg, 2012; 43: 322-328","DOI":"10.1016\/j.ejvs.2011.12.001"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Hata Y, Iida O, Okamoto S, Ishihara T, Nanto K, Tsujumura T, Takahara M and Mano T: Additional Risk Stratification Using Local and Systemic Factors for Patients with Critical Limb Ischaemia Undergoing Endovascular Therapy in the WIfI Era. Eur J Vasc Endovasc Surg, 2019; 58: 548-555","DOI":"10.1016\/j.ejvs.2019.06.005"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Hata Y, Iida O, Asai M, Masuda M, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujumura T, Okuno S, Matsuda Y, Takahara M and Mano T: Risk Stratification for 2-Year Mortality in Patients with Chronic Limb-Threatening Ischemia Undergoing Endovascular Therapy. J Atheroscler Thromb, 2021; 28: 477-482","DOI":"10.5551\/jat.57711"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Kodama A, Takahara M, Iida O, Soga Y, Terashi H, Kawasaki D, Izumi Y, Mii S, Komori K and Azuma N: Ambulatory Status Over Time after Revascularization in Patients with Chronic Limb-Threatening Ischemia. J Atheroscler Thromb, 2022; 29: 866-880","DOI":"10.5551\/jat.62892"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Sano M, Yamamoto K, Seo A, Akai A, Akagi D, Takayama T and Hoshina K: Wound healing after revascularization for critical limb ischemia. Int Angiol, 2019; 38: 225-229","DOI":"10.23736\/S0392-9590.19.04096-3"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Seo A, Yamamoto K, Akai A, Akagi D, Takayama T and Hoshina K: The relationship between medical expenses and the severity of peripheral arterial disease in Japan. Heart Vessels, 2018; 33: 853-858","DOI":"10.1007\/s00380-018-1127-3"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Reinecke H, Unrath M, Freisinger E, Bunzemeier H, Meyborg M, Luders F, Gebauer K, Roeder N, Berger K and Malyar NM: Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J, 2015; 36: 932-938","DOI":"10.1093\/eurheartj\/ehv006"},{"key":"31","unstructured":"31) Fife CE and Carter MJ: Wound Care Outcomes and Associated Cost Among Patients Treated in US Outpatient Wound Centers: Data From the US Wound Registry. Wounds, 2012; 24: 10-17"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Lovell M, Harris K, Forbes T, Twillman G, Abramson B, Criqui MH, Schroeder P, Mohler ER, 3rd and Hirsch AT: Peripheral arterial disease: lack of awareness in Canada. Can J Cardiol, 2009; 25: 39-45","DOI":"10.1016\/S0828-282X(09)70021-2"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM and Hiatt WR: Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA, 2001; 286: 1317-1324","DOI":"10.1001\/jama.286.11.1317"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Creager MA, Matsushita K, Arya S, Beckman JA, Duval S, Goodney PP, Gutierrez JAT, Kaufman JA, Joynt Maddox KE, Pollak AW, Pradhan AD and Whitsel LP: Reducing Nontraumatic Lower-Extremity Amputations by 20% by 2030: Time to Get to Our Feet: A Policy Statement From the American Heart Association. Circulation, 2021; 143: e875-e891","DOI":"10.1161\/CIR.0000000000000967"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Golledge J and Drovandi A: Evidence-Based Recommendations for Medical Management of Peripheral Artery Disease. J Atheroscler Thromb, 2021; 28: 573-583","DOI":"10.5551\/jat.62778"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36) Ban S, Sakakura K, Jinnouchi H, Taniguchi Y, Tsukui T, Watanabe Y, Yamamoto K, Seguchi M, Wada H and Fujita H: Association of Asymptomatic Low Ankle-Brachial Index with Long-Term Clinical Outcomes in Patients after Acute Myocardial Infarction. J Atheroscler Thromb, 2021; doi: 10.5551\/jat.62998","DOI":"10.5551\/jat.62998"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Tomoi Y, Takahara M, Soga Y, Fujihara M, Iida O, Kawasaki D, Kozuki A and Ando K: Prognostic Value of the CHA2DS2-VASc Score after Endovascular Therapy for Femoral Popliteal Artery Lesions. J Atheroscler Thromb, 2021; 28: 1153-1160","DOI":"10.5551\/jat.60772"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Takahara M, Iida O, Soga Y, Azuma N and Nanto S: Clinical Impact of Measures for Frailty Severity in Poor-Risk Patients Undergoing Revascularization for Chronic Limb-Threatening Ischemia. J Atheroscler Thromb, 2022; 29: 221-228","DOI":"10.5551\/jat.61481"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Higashino N, Iida O, Hata Y, Asai M, Masuda M, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Okuno S, Matsuda Y, Takahara M and Mano T: Impact of Longer Hemodialysis Vintage with Higher Serum Phosphorus Level on Clinical Outcomes in Patients with Chronic Limb-Threatening Ischemia Presenting Tissue Loss after Endovascular Therapy. J Atheroscler Thromb, 2022; 29: 370-378","DOI":"10.5551\/jat.60095"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Takahara M, Soga Y, Fujihara M, Kawasaki D, Kozuki A and Iida O: Association of Age with Mortality Rate after Femoropopliteal Endovascular Therapy for Intermittent Claudication. J Atheroscler Thromb, 2022; 29: 474-481","DOI":"10.5551\/jat.62356"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/3\/30_63593\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T04:35:14Z","timestamp":1677904514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/3\/30_63593\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.63593","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"article-number":"63593"}}